In this study, we have shown that COVID-19 cases present increased deposition of collagen, fibronectin, versican, and TGF-β in the lungs when compared to non-COVID-19 ARDS cases of similar ventilation duration. This evidence concerns the gene FN1 and acute respiratory distress syndrome.